News | January 22, 2008

Researchers Simulate World’s Largest Heart Model

January 22, 2008 - Researchers at the Universite de Montreal have run the largest mathematical simulation of a heart, a two billion element model, enabling discoveries of the electrical triggers of the various kinds of heart disease that could lead to earlier diagnosis and new treatments.
Run on a high-performance computing system from SGI, the new Universite de Montreal model is up to 1,000 times more detailed than previous models.
Until recently, the largest heart models in the world had at most a few million elements. Over the last nine months, Dr. Mark Potse and Dr. Alain Vinet, both affiliated with the Research Center of Sacre-Coeur Hospital and the Biomedical Engineering department at Universite de Montreal, began running 100 to 120 million-point models as part of their heart disease research on an SGI Altix 4700 system.
In late October, Dr. Potse and Vinet ran a custom electrocardiography (ECG) code, using the entire SGI Altix system and 1.2TB of shared memory. The ECG code made the leap from 120 million points to two billion.
Dr. Potse simulated 5 milliseconds of activation in a tissue block that included some properties of a real heart, such as fiber running in different directions. The simulation solved a system of 2 billion equations a dozen times. The test took two hours, which Dr. Potse describes as short for achieving the desired results. A full heartbeat, he says, would take two weeks, and they cannot claim use of the entire machine for that length of time right now.
With disease such as Brugada syndrome and Long-QT syndrome, which can cause sudden death in young, otherwise healthy people, there are typical changes in the ECG that allow doctors to diagnose these diseases. In order to understand what the mechanisms of the particular disease are, the heart must be modeled with enormous detail. Without the use of computer models it can be hard to track the effects of a heart disease on the ECG.

For more information: www.umontreal.ca

Related Content

FDA Clears AliveCor's KardiaMobile 6L as First Six-Lead Personal ECG Device
Technology | ECG | May 13, 2019
AliveCor announced its third U.S. Food and Drug Administration (FDA) clearance in three months, making KardiaMobile 6L...
One innovation in ECG is its use in the customer wearable market, which will tie more closely into the clinical world either with using the data to triage patients and/or patients seeking medical attention prior to acute symptoms appearing.

One innovation in ECG is its use in the customer wearable market, which will tie more closely into the clinical world either with using the data to triage patients and/or patients seeking medical attention prior to acute symptoms appearing.

Feature | ECG | May 03, 2019 | Sanket Solanki
Technology has made its way into the healthcare sector and brought a drastic transformation.
Videos | ECG | March 05, 2019
This is a quick demo of the Schiller Cardiovit FT-1 electrocardiograph (ECG) system displayed at the ...
EKG With Artificial Intelligence Reliably Detects Heart Failure Precursor
News | ECG | January 08, 2019
January 8, 2019 — A Mayo Clinic study finds that applying...
Use of traditional Holter monitor leads can be an issue for patient compliance and comfort. The newer generation ambulatory cardiac monitors use an adhesive patch that sticks directly on the patient's chest and allows them to shower and go about daily activities without a belt mounted monitor or leads getting in the way. This is especially important for longer term monitoring of seven days or longer.

Use of traditional Holter monitor leads can be an issue for patient compliance and comfort. The newer generation ambulatory cardiac monitors use a small, adhesive patch that sticks directly on the patient's chest and allows them to shower and go about daily activities without a belt mounted monitor or leads getting in the way. This is especially important for longer term monitoring of seven days or longer. 

Feature | ECG | September 27, 2018
Advances in the technology of wearable cardiac monitors are improving both the experience of the patient and the effe
HeartSciences MyoVista ECG Device Shows Promise in Detecting Abnormal Cardiac Function
News | ECG | April 27, 2018
HeartSciences announced the results of a clinical study of its electrocardiography device that applies continuous...
ECG Study of NBA Players Shows Need for Sport-Specific Normative Data and Guidelines
News | ECG | December 08, 2017
Cardiologists at NewYork-Presbyterian/Columbia University Irving Medical Center compared electrocardiographic findings...
HeartSciences Announces CE Mark and European Launch of MyoVista High Sensitivity ECG

Just as a Doppler radar color image shows the energy of a storm, MyoVista provides physicians a detailed visual image of the energy distribution during the cardiac cycle.

News | ECG | August 22, 2017
HeartSciences announced the European launch of the MyoVista high sensitivity electrocardiograph (hsECG) Testing Device...
AUM Cardiovascular Receives FDA Approval for CADence ECG Device
Technology | ECG | August 08, 2017
AUM Cardiovascular announced it has received clearance from the U.S. Food and Drug Administration (FDA) for CADence, a...
More Than 20 Percent of Low-Risk Patients Receive Annual ECG
News | ECG | July 20, 2017
July 20, 2017 — More than one in five Ontario patients receive an ...
Overlay Init